Management of Median Arcuate Ligament Syndrome (MALS) with Decompression and Coeliac Ganglion Sympathectomy (CGS) for Chronic Mesenteric Ischaemia (CMI). Procedural, Clinical and Enduring Results With Quality-Adjusted Time Spent Without Symptoms of Disease and Toxicity of Treatment (Q-TWiST)

SHERIF SULTAN

Management of Median Arcuate Ligament Syndrome (MALS) with Decompression and Coeliac Ganglion Sympathectomy (CGS) for Chronic Mesenteric Ischaemia (CMI). Procedural, Clinical and Enduring Results With Quality-Adjusted Time Spent Without Symptoms of Disease and Toxicity of Treatment (Q-TWiST)

Surgery

Research output: Other contribution (Published) › Other contribution

Original language	English (Ireland)
Media of output	Abstract
Volume	51
Publication status	Published - 1 Jun 2010

Cite this

@misc{5c458dd50dff4d7fab411c75b5d78abf,

title = "Management of Median Arcuate Ligament Syndrome (MALS) with Decompression and Coeliac Ganglion Sympathectomy (CGS) for Chronic Mesenteric Ischaemia (CMI). Procedural, Clinical and Enduring Results With Quality-Adjusted Time Spent Without Symptoms of Disease and Toxicity of Treatment (Q-TWiST)",

author = "SHERIF SULTAN",

year = "2010",

month = jun,

day = "1",

language = "English (Ireland)",

volume = "51",

type = "Other",

}

Management of Median Arcuate Ligament Syndrome (MALS) with Decompression and Coeliac Ganglion Sympathectomy (CGS) for Chronic Mesenteric Ischaemia (CMI). Procedural, Clinical and Enduring Results With Quality-Adjusted Time Spent Without Symptoms of Disease and Toxicity of Treatment (Q-TWiST). / SULTAN, SHERIF.
2010.

Research output: Other contribution (Published) › Other contribution

TY - GEN

T1 - Management of Median Arcuate Ligament Syndrome (MALS) with Decompression and Coeliac Ganglion Sympathectomy (CGS) for Chronic Mesenteric Ischaemia (CMI). Procedural, Clinical and Enduring Results With Quality-Adjusted Time Spent Without Symptoms of Disease and Toxicity of Treatment (Q-TWiST)

AU - SULTAN, SHERIF

PY - 2010/6/1

Y1 - 2010/6/1

M3 - Other contribution

VL - 51

ER -